Showing results (121-130 of 132) with videos related to
Sort By:
Pageof 14
Cancer Biology & Therapy|February 11, 2011
Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2James W Antoon, Martin D White, Evelyn M Slaughter, et al.Journal of Molecular Endocrinology|February 16, 2011
Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancerJames W Antoon, William D Meacham, Melyssa R Bratton, et al.Journal of Cellular Physiology|September 13, 2005
Long term metabolic arrest and recovery of HEK293 spheroids involves NF-kappaB signaling and sustained JNK activationGraham D Jack, E Andrew Mead, James F Garst, et al.Implementation Science : IS|November 28, 2007
The Ontario printed educational message (OPEM) trial to narrow the evidence-practice gap with respect to prescribing practices of general and family physicians: a cluster randomized controlled trial, targeting the care of individuals with diabetes and hypertension in Ontario, CanadaMerrick Zwarenstein, Janet E Hux, Diane Kelsall, et al.Health Physics|March 22, 2002
The historical and current application of the FIB-1 model to assess organ dose from plutonium intakes in Mayak workersMelinda P Krahenbuhl, David M Slaughter, Justin L Wilde, et al.Endocrinology|September 24, 2010
Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640James W Antoon, Martin D White, William D Meacham, et al.Biorxiv : the Preprint Server for Biology|February 27, 2026
Daraxonrasib (RMC-6236) is an effective targeted therapy for <i>RAS</i> -mutant neuroblastomaRonald D Hill, Krista M Dalton, Richard Kurupi, et al.Health Physics|February 28, 2008
Predictability of acute radiation injury severityTamara V Azizova, Sergey V Osovets, Richard D Day, et al.Heart Rhythm|September 9, 2008
Design and implementation of a population-based registry of Implantable Cardioverter Defibrillators (ICDs) in OntarioDouglas S Lee, David Birnie, Douglas Cameron, et al.Research Square|June 17, 2024
Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial SarcomaKonstantinos V Floros, Carter K Fairchild, Jinxiu Li, et al.Pageof 14